{"id":3747,"date":"2017-04-17T03:53:29","date_gmt":"2017-04-17T03:53:29","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=3747"},"modified":"2017-04-17T15:53:54","modified_gmt":"2017-04-17T15:53:54","slug":"ensayan-farmaco-de-diseno-para-hipercolesterolemia","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2017\/04\/17\/ensayan-farmaco-de-diseno-para-hipercolesterolemia\/","title":{"rendered":"Ensayan f\u00e1rmaco de dise\u00f1o para hipercolesterolemia"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2017\/04\/2017-04-16-Inclisiran.jpg\"><img loading=\"lazy\" class=\"alignleft wp-image-3788 size-full\" style=\"border-width: 1px;margin: 5px\" title=\"(c) Ray KK, et al. N Eng J Med 2017\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2017\/04\/2017-04-16-Inclisiran.jpg\" alt=\"2017 04 16 Inclisiran\" width=\"85\" height=\"67\" \/><\/a>Inclisiran, un ARN peque\u00f1o de interferencia sintetizado qu\u00edmicamente para unirse al ARNm de <a title=\"Informaci\u00f3n sobre el gen en Gene\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/255738\" target=\"_blank\">PCSK9<\/a>, ha mostrado en un ensayo cl\u00ednico fase II su capacidad de reducir significativamente los niveles de LDL colesterol. Los detalles est\u00e1n en Ray KK, Landmesser U, Leiter LA, Kallend D, Dufour R, Karakas M, <em>et al<\/em>. <a title=\"Texto completo en ingl\u00e9s\" href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1615758#t=article\" target=\"_blank\">Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol<\/a>. N Eng J Med March 17, 2017; DOI: 10.1056\/NEJMoa1615758.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Inclisiran, un ARN peque\u00f1o de interferencia sintetizado qu\u00edmicamente para unirse al ARNm de PCSK9, ha mostrado en un ensayo cl\u00ednico fase II su capacidad de reducir significativamente los niveles de LDL colesterol. Los detalles est\u00e1n en Ray KK, Landmesser U, Leiter LA, Kallend D, Dufour R, Karakas M, et al. Inclisiran in Patients at High [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3747"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=3747"}],"version-history":[{"count":4,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3747\/revisions"}],"predecessor-version":[{"id":3797,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3747\/revisions\/3797"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=3747"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=3747"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=3747"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}